期刊文献+

GnRHa对离体培养异位、在位内膜间质细胞生长抑制及分泌VEGF的影响 被引量:3

Effect of GnRHa on cell proliferation and VEGF's secreting of ectopic and eutopic stromal cells from patients with endometriosis in vitro
下载PDF
导出
摘要 目的研究GnRHa对子宫内膜异位症(简称内异症)患者离体培养异位、在位子宫内膜间质细胞生长抑制及分泌VEGF的影响。方法体外原代培养人内异症异位、在位子宫内膜间质细胞,用10-10M、10-8M和10-6M的GnRHa分别干预,用MTT法测定内膜间质细胞的生长增殖情况;用ELISA法测定其分泌的血管内皮生长因子(VEGF)浓度的变化。结果 GnRHa可抑制内异症异位及在位内膜间质细胞的生长增殖,呈剂量和时间依赖性(P<0.05),且对异位内膜间质细胞生长的抑制率明显高于在位(P<0.05);GnRHa可降低异位及在位内膜间质细胞分泌的VEGF的浓度,呈剂量依赖性(P<0.05),且高浓度(10-6M)对异位强于在位(P<0.05)。结论 GnRHa可明显抑制子宫内膜异位症患者异位、在位子宫内膜间质细胞的生长,降低其分泌VEGF的浓度。 [Objective] To investigate the effect of GnRHa on the cell proliferation and VEGF's secreting of ectopic and eutopic endometrial stromal cells from patients with endometriosis(EMs) in vitro. [ Methods ] The eetopic and eutopic endometrlal stromal cells were isolated, cultured and identified in vitro, then added to 10-10M, 10-8M, 10-6M GnRHa. The growth and proliferation of ectopic and eutopic stromal cells were measured by MTT assay; ELISA was used to measure the VEGF concentration change. [Results] GnRHa can inhibit the proliferation of ectopic and eutopic endometrial stromal cells from patients with endometriosis, in a dose-and time- dependent manner (P 〈0.05), and the effect on ectopie was stronger than the eutopie (P 〈0.05); The concentration of VEGF in ectopic and eutopic cells was significantly decreased after the treatment of GnRHa, in a dose-dependent manner(P 〈 0.05), and the ectopic was lower than the eutopic in lO-6M GnRHa (P 〈0.05). [Conclusion] GnRHa can significantly inhibit the cell proliferation of ectopic and eutopic endometrial stromal cells of EMs and decrease the secretion of VEGF.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第1期79-83,86,共6页 China Journal of Modern Medicine
关键词 促性腺素释放激素激动剂 异位内膜间质细胞 在位内膜间质细胞 细胞增殖 抑制 血管内皮生长因子 GnRHa gonadorelin eutopic endometrial stromal cell ectopic endometrial stromal cells cell proliferation VEGF in vitro
  • 相关文献

参考文献10

  • 1DEVERIM A, ARIF K, MIGRACI T, et al. Comparison of the effects of cetrorelix, a GnRH antagonist, and leuprolide, a GnRH agonist, on experimental endometriosis[J]. Journal of Obstetrics and Gynaecology Research, 2008, 34(6): 1014-1019.
  • 2QIN LH, QIN MC, LI S, et al. Human endometrial ceUs in primary in vitro culture methods[J]. Hunan University of Chinese Medicine, 2007, 27(3): 8-10. Chinese.
  • 3CHEN jL, LIN QH, FANG XL, et al. Progesterone on the ectopic endometrial stromal cells in MMP-2 and MMP-9 expression in Effects[J]. Jonmal of Central South University: Medicine Edition, 2005, 30 (3): 307-311. Chinese.
  • 4MERESMAN GF, BILOTAS MA, LOMBARDI E, et al. Effect of GnRH analogues on apoptosis and release of interleukin-lbeta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis[J]. Hum Reprod, 2003, 18(9): 1767-1771.
  • 5MERESMAN GF, BILOTAS MA, BUQUET RA, et al. Gonadotrop in releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis [J]. Fertil Steril, 2003, 80(Suppl2): 702-707.
  • 6HAN LW, JIANG WG. GnRHa for endometriosis growth and proliferation of endometrial stromal cells and vascular formation [J]. Modem progress in Obstetrics and Gynecology, 2008, 17 (10): 737-739. Chinese.
  • 7ZHEN Z, DALE N, SHANE T, et al. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometfiosis[J]. Molecular Human Reproduction, 2008, 14(9): 531-538.
  • 8GILABERT-ESTELLES J, RAMON LA, ESPANA F, et al. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems [J]. Human Reproduction, 2007, 22 (8): 2120-2127.
  • 9EUN HS, YOUNG LJ, HYE-SUNG M, et al. Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis[J]. Molecular Human Reproduction, 2006, 12(7): 421-426.
  • 10CPdSTIN P, REUA V, AMANDA E, et al. Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell. transcriptome[J]. Human Reproduction, 2004, 19(10): 2356-2366.

同被引文献13

  • 1冷金花,郎景和,戴毅,李华军,李晓燕.子宫内膜异位症患者疼痛与盆腔病灶解剖分布的关系[J].中华妇产科杂志,2007,42(3):165-168. 被引量:79
  • 2Kwang Wook An,Erik R Nelson,Hamid R. Habibi,et al. Molecular char- acterization and expression of three GnRH forms mRNA during gonad sex - change process, and effect of GnRHa on GTH subunits mRNA'in the pro- tandrous black porgy (Acanthopagrus schlegeli) [ J]. General and Compara- tive Endocrinology ,2008, Vol ( 159 ) :38 - 45.
  • 3Borroni R, Di Blasio A M, Gaffuri B, et al. Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferationby leuprolide acetate [ J ]. Mol Cell Endoerinol,2000, ( 1 - 2 ) :37 - 43.
  • 4Bilotaa M, Baranao RI, Buquet R, et aI. Effect of GnRH analogues on ap- optoals and expression of Bcl -2, Bax, Fas and Fasl proteins in enclometfi- al epithelial cell cultures from patients with endometriosia and controls [ J]. Hum Reprod, 2007, 22 ( 3 ) : 644 - 653.
  • 5Deng S, Lang JH, Leng JH, et al. Effects of medical treatment on apoptosis in eutopie endometrium of patients with endometriosis [J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2007, 29 (2) : 252 - 256.
  • 6Ishihara H, K/tawaki J, Kado N, et aI. Gonadotropin -releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eu- topic endometrium from women with endometriosis, odenomyosis or leiomyo- mas[JJ. Fertil Steril, 2003,79(3) :735 -742.
  • 7Olive DL. Optimizing gonadotropin - releasing hormone agonist therapy in women with endometriosis [ J ]. Treat Endocrino, 2004, 3 (2) : 83 - 89.
  • 8Masahiro T, Tetsu M, Takeshi Y, et al. Treatment of endometriosis with a decreasing dosage of a gonadotrepin releasing hormone agonist (nafarelin) : a pilot study with low - dose agonist therapy ( " draw - back" therapy) [J]. Fertil Steril, 2000, 73(4) : 800 -804.
  • 9Loverro G, Carriem C, Rossi AC,et al. A randomized study comparing triptorelin or expectant management following conservative laparoscopic sur- gery for symptomatic stage Ⅲ -Ⅳ endometfiosis [ J ]. Eur J Obatet Gynecol Reprod Biol, 2008,136(2) :194 - 198.
  • 10Fernandez H, Lucas C, Hedon B, et al. One year comparison between two add - back therapies in patients treated with a GnRH agonist for symp- tomatic: a randomized double - blind trial [ J ]. Hum Reprod, 2004, 19 (6) :1465 - 1471.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部